Archives for December 2, 2009

← 2009

GM soy researched for omega-3 potential

By Mike Stones

A new source of omega-3 produced from soybean oil derived from genetically-modified plants could safeguard supplies and protect dangerously depleted world fish stocks.

SunOpta enters South African soy alliance

Canadian natural and organics group SunOpta has entered into a strategic alliance with Specialized Protein Products of South Africa, to increase its profitability and access to soy ingredient markets.

Omega-3 maker reacts to negative health claim opinions

By Shane Starling

UK-based omega-3 supplements brand, Equazen, says it will amend its marketing materials after negative health claim opinions regarding its products were written into the European Union legislature in October.

Probiotics: From clinical trial to health claims success

By Stephen Daniells

As a raft of non-positive opinions on probiotics floats down the health claims river, questions have been asked of the efficacy of the beneficial bacteria. Two experts discuss where we stand and how to get the good ship Probiotic back on course.

Kemin and OmniActive settle lutein patent dispute

By Shane Starling

Kemin Foods and OmniActive Health Technologies have settled a long-standing, lutein processing patent dispute that was due to be heard by a Florida court jury in July, 2010.

Probiotic research needed to fulfill gut health potential

By Guy Montague-Jones

Probiotics should be considered as living drugs rather than “simple good bacteria” in order to become effective treatment options for IBS, according to Joseph Haddad, medical director of Institut Rosell-Lallemand.